Pfizer Corporation

Paige Roanne Palmer Brooks

Jotham Wadsworth Coe

This invention is directed to compounds of the formula (I): and their pharmaceutically acceptable salts, wherein R, R, and Rare as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.

Aryl fused azapolycyclic compounds

Pharmaceutical compositions comprising compounds of the formulaand their pharmaceutically acceptable salts, wherein R, R, and Rare defined as in the specification, in combination with another therapeutic agent and methods of using such combinations in the treatment of neurological and psychological disorders.

Compounds of the formulaand their pharmaceutically acceptable salts, wherein R, R, and Rare defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders.

Growing community of inventors

North Stonington, CT, United States of America

Paige Roanne Palmer Brooks